Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Early Phase 1
Contacts and Locations
Study Contact
Study Contact
- Name: Jacqueline K Limberg, Ph.D.
- Phone Number: 573-882-2544
- Email: limbergj@missouri.edu
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65211
- University of Missouri-Columbia
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-45 years of age (premenopausal)
- Healthy weight (BMI ≥18 and ≤25 kg/m2)
- Obese (BMI ≥30 kg/m2)
Exclusion Criteria:
- Pregnancy, breastfeeding, oral hormonal contraceptive use
- Diagnosed sleep apnea or Oxygen desaturation index >10 events/hr
- Current smoking/Nicotine use
- Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
- Nerve/neurologic disease
- Cardiovascular, hepatic, renal, respiratory disease
- Blood pressure ≥140/90 mmHg
- Diabetes, Polycystic ovarian syndrome
- Communication barriers
- Prescription medications, Sensitivity to lidocaine
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Hypoxia Exposure
Participants will undergo room air (normoxic) and low oxygen (hypoxic) conditions.
|
Participants will complete the cold pressor test during the final 2 min of normoxia and hypoxia.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in forearm vascular conductance with cold pressor test
Time Frame: Continuous measurement of vascular conductance during cold pressor test (final 2 min of normoxia and hypoxia).
|
Vascular conductance is an index of vascular tone and is measured using a technique called venous occlusion plethysmography.
|
Continuous measurement of vascular conductance during cold pressor test (final 2 min of normoxia and hypoxia).
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Vascular Diseases
- Cardiovascular Diseases
- Nutrition Disorders
- Overnutrition
- Body Weight
- Overweight
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Obesity
- Aneurysm
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Central Nervous System Depressants
- Sensory System Agents
- Analgesics, Non-Narcotic
- Analgesics
- Neurotransmitter Agents
- Hypnotics and Sedatives
- Protective Agents
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Adrenergic Agents
- Respiratory System Agents
- Cardiotonic Agents
- Antihypertensive Agents
- Adrenergic Antagonists
- Sympathomimetics
- Vasoconstrictor Agents
- Mydriatics
- Adrenergic alpha-Antagonists
- Nasal Decongestants
- Adrenergic alpha-1 Receptor Agonists
- Dexmedetomidine
- Norepinephrine
- Oxymetazoline
- Phenylephrine
- Phentolamine
Other Study ID Numbers
Other Study ID Numbers
- 2022525
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.